What Is Sancuso? Sancuso (granisetron) is a prescription transdermal patch used to prevent chemotherapy-induced nausea and vomiting (CINV) for up to five days. As a 5-hydroxytryptamine 3 (5-HT3) receptor antagonist (5-HT3-RA), it works by
Sancuso (granisetron) is a prescription transdermal patch used to prevent chemotherapy-induced nausea and vomiting (CINV) for up to five days. As a 5-hydroxytryptamine 3 (5-HT3) receptor antagonist (5-HT3-RA), it works by blocking 5-HT3 receptors (binding sites).
The 5-HT3 receptors are located in specific parts of your nervous system. When your body is exposed to certain factors—like chemotherapy, enterochromaffin cells (EC) are thought to release serotonin, a naturally occurring chemical in the body.
However, when serotonin from EC attaches to 5-HT3 receptors, people tend to experience nausea and vomiting. Sancuso prevents nausea and vomiting by blocking 5-HT3 receptors, which inhibit serotonin from attaching to these binding sites.
Sancuso is a transdermal patch, meaning it is applied to your skin.
Generic Name: Granisetron
Brand Name: Sancuso
Drug Availability: Prescription
Administration Route: Transdermal
Therapeutic Classification: Antiemetic
Available Generically: No
Controlled Substance: N/A
Active Ingredient: Granisetron
Dosage Form: Extended-release patch
The Food and Drug Administration (FDA) approved Sancuso to prevent nausea and vomiting in adults receiving chemotherapy for up to five days.
There are different treatments and medications available to treat cancer. Chemotherapy (chemo) is a potential option. Unfortunately, about 80% of people receiving chemo experience nausea and vomiting. This side effect is also known as chemotherapy-induced nausea and vomiting (CINV).
There are different types of CINV, which include:
In addition to negatively affecting your quality of life, CINV can lead to malnutrition due to appetite loss, tears in the esophagus (hollow tube that sending food from your mouth to your stomach), and fractures.
Some people have a higher chance of experiencing CINV. Risk factors may include:
Other than the above risk factors, some chemo treatments are more likely to cause nausea and vomiting. Chemotherapy drugs can be divided into three groups according to their risk level, including:
Medication regimens to prevent nausea and vomiting can vary based on the chemo's risk level. Although experts mention Sancuso as a potential prevention option for each risk category, the FDA only approved Sancuso for moderate or high-risk chemo treatments.
Discuss any questions or concerns with your healthcare practitioner or pharmacist.
The following are general directions to use Sancuso:
The following is additional information to keep in mind while using Sancuso.
When you receive your Sancuso patches from the pharmacy, keep the patches at room temperature (between 68 degrees to 77 degrees Fahrenheit). It is acceptable to keep for a short while in temperatures between 59 and 86 degrees. Be sure to place this medication out of reach of children and pets.
Additionally, keep Sancuso in its original packaging, and don’t remove the patch from the pouch until you’re ready to use it.
If you’re planning to travel with Sancuso, become familiar with the regulations of your final destination first. Keep Sancuso in its original container from the pharmacy, and make sure the packaging has a label with your name on it. Also, make a copy of your Sancuso prescription and bring it with you.
In addition to chemotherapy, some people experience nausea and vomiting after surgery or a procedure. Experts have used Sancuso before the end of surgery to prevent these side effects.
Sancuso may work as fast as one to two days before your chemotherapy treatment period's first day of chemo. However, for the effects to last, you will need to continue using the patch until one to three days after your last chemo day of the chemotherapy treatment period.
This is not a complete list of side effects and others may occur. A medical professional can advise you on side effects. If you experience other effects, contact your pharmacist or a medical professional. You may report side effects to the FDA at www.fda.gov/medwatch or 800-FDA-1088.
Some common side effects with Sancuso may include:
The following are some potentially severe side effects with Sancuso.
Sancuso is usually only used for up to seven days at a time, which isn’t typically considered long-term use.
After taking off the patch for three days, some people have noticed skin redness where the patch was placed. While the skin redness is normal, immediately inform your healthcare provider if your skin reactions spread to other parts of your body other than where the patch was applied.
Additionally, for 10 days after taking off the patch, don’t expose the application site to natural or artificial sunlight. Wear clothes that will cover and protect the upper outer arms to prevent skin reactions.
Sancuso may cause other side effects. Call your healthcare provider if you have any unusual problems while taking this medication. If you experience a serious side effect, you or your provider may send a report to the FDA's MedWatch Adverse Event Reporting Program or by phone (800-332-1088).
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
In certain cases, your healthcare provider may adjust your dosage of Sancuso or monitor you more closely while taking this medication.
Children
There is no safety or effectiveness information on Sancuso in children.
People With a Recent Surgical History in the Stomach Area
If you recently had surgery in your stomach area, you might have a higher risk of digestive system problems with Sancuso.
Although your healthcare provider will monitor your bowel activity, notify them of new or worsening constipation. Get medical help right away if you’re experiencing swelling or pain in the stomach area.
Pregnancy and Breastfeeding
Based on available data of Sancuso use during pregnancy, the medication isn’t linked to any negative effects on the fetus. However, more information is needed. As for breastfeeding, there is little safety and effectiveness data on Sancuso in nursing babies. Therefore, experts recommend using this medication with caution while nursing.
If you accidentally forgot to wear your Sancuso patch within 24 hours of the first day of your chemo in your chemotherapy treatment cycle, contact your healthcare provider as soon as possible.
If you forgot to use the patch at least one day before this appointment, you might experience nausea and vomiting due to your chemotherapy. You and your healthcare provider will need to discuss next steps and make sure that you get your treatment with minimal side effects.
If you accidentally apply too many Sancuso patches, overdose symptoms may include headaches.
If you think you or someone else may have overdosed on Sancuso, call a healthcare provider or the Poison Control Center (800-222-1222). If someone collapses, has a seizure, has trouble breathing, or can’t wake up after taking too much Sancuso, call 911 immediately.
Check with your doctor if severe nausea and vomiting continue after leaving the hospital or cancer treatment center.
Do not take other medicines containing granisetron while using Sancuso®. Using these medicines together may cause serious unwanted side effects.
Check with your doctor right away if you start to have pain or swelling in your stomach area. These may be signs of a serious stomach or bowel problem.
Check with your doctor right away if you have anxiety, restlessness, a fast heartbeat, fever, sweating, muscle spasms, twitching, nausea, vomiting, diarrhea, or see or hear things that are not there. These may be symptoms of a serious condition called serotonin syndrome. Your risk may be higher if you also take certain other medicines that affect serotonin levels in your body.
Serious skin reactions may occur while using the patch. Check with your doctor right away if you have a skin rash, itching, redness, or any skin irritation while you are wearing the patch.
Do not use a heating pad or heat lamp near the Sancuso® patch. Avoid sunlamps and tanning beds while using this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Avoid using this patch if you have had a severe allergic reaction to Sancuso or its components.
As previously mentioned, Sancuso combined with certain medications can raise your risk of serotonin syndrome. Medications linked to this syndrome tend to increase serotonin amounts in the body. Examples of these medications are selective serotonin reuptake inhibitors (SSRIs)—like Prozac (fluoxetine) or Zoloft (sertraline)—and serotonin-norepinephrine reuptake inhibitors (SNRIs)—like Effexor XR (venlafaxine) or Cymbalta (duloxetine).
The 5-HT3-RA medication class is just one option to prevent CINV. In addition to Sancuso, the small 5-HT3-RA class includes the following:
Sancuso is the only 5-HT3-RA medication that is available as a patch. Some people might prefer a patch over other options—like tablets that they might throw up.
Since all of these medications are 5-HT3-RAs used for nausea and vomiting, they typically aren’t used together. However, the exception might be ondansetron (including Zofran), which has been used for CINV that is acute (severe and sudden but short-lived) and breakthrough (a flare that may occur even when taking medicine to prevent it). It’s also available as a cost-effective generic medication at many local retail pharmacies. People use ondansetron one to three times daily as needed for a few days after a chemo treatment.
Talk with your healthcare provider if you have any questions about different options to help prevent and control your CINV side effects.
Sancuso is available as a prescription from your healthcare provider. However, your healthcare provider may need to send the prescription to a specialty pharmacy. Your local retail pharmacy might not carry Sancuso.
Since Sancuso is a brand-name medication, it’s typically expensive. If cost is a concern, the manufacturer—Kyowa Kirin—offers co-pay assistance cards. There’s also a Patient Rx Solutions program to help people who don't have insurance. If additional help is needed, consider contacting 800-6-SOLUTIONS.
Although patches may fall off, this happens very rarely. However, if your patch does entirely fall off, the manufacturer does offer a replacement program. You can also request a replacement patch if your chemotherapy treatment period is delayed or canceled.
Let your healthcare provider know if you’re still experiencing nausea and vomiting with Sancuso. Your healthcare provider will make additions or changes to your CINV medications to help prevent and control these side effects.
Adding chemotherapy to your to-do list can make life even busier. Consider talking with your loved ones to help with certain tasks—like assisting you with the drive to the cancer center and other responsibilities. Websites—like Caring Bridge or Lotsa Helping Hands—can also help update loved ones about your treatments and organize tasks.
As for nausea, there are steps you can take in addition to taking Sancuso and other CINV medications. In general, you can try the following:
For vomiting, keep the following in mind:
For additional tips, visit the American Cancer Society website. Also, talk with your healthcare provider or pharmacist.
Verywell Health's drug information is meant for educational purposes only and is not intended as a replacement for medical advice, diagnosis, or treatment from a healthcare professional. Consult your healthcare provider before taking any new medication(s). IBM Watson Micromedex provides some of the drug content, as indicated on the page.